• Home
  • Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy".

Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy".

Author List
Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ
Publication
Journal of the American Chemical Society
Publication ID (Profile URL)
https://researcherprofiles.org/profile/392961350
Publication Year
2016
PubMed ID
26916820
Publication Title
Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ. Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy". J Am Chem Soc. 2016 Mar 09; 138(9):3250.